Stay updated with breaking news from Resented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
May 11, 2023 Late-breaking data presented from largest-ever randomized controlled multicenter clinical trial on optimizing patient safety during coronary proceduresPhilips-hosted symposiums and... | May 11, 2023
RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive Impairment Associated with Schizophrenia.GRX-917: Presented PD data from the completed Phase 1 study, which suggest the... | May 11, 2023
Data Will Also Be Presented in a Poster Session at the American Society of Clinical Oncology Annual Meeting on June 3, 2023 SOUTH SAN FRANCISCO, Calif., May 11, 2023 -- Allogene Therapeutics,... | May 11, 2023
Poster presentation will highlight durable, long-term responses in relapsed/refractory DLBCL patients treated with ZYNLONTA ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2
Presented initial preclinical data from ETX-123, Eliem's lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed mechanism of action on neuronal excitability ... | May 11, 2023